Followers | 3820 |
Posts | 238866 |
Boards Moderated | 0 |
Alias Born | 07/30/2007 |
Wednesday, March 30, 2016 10:12:26 AM
7:30 AM ET 3/30/16 | GlobeNewswire
Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine Systems, received FDA clearance of the Xspan(TM) Laminoplasty Fixation System.
About the Xspan(TM) Laminoplasty Fixation System
The Xspan(TM) System represents the latest generation of laminoplasty fixation. Spinal laminoplasty is a surgical procedure performed to remove pressure from the spinal cord. Unlike a laminectomy, where the entire lamina is removed, only an opening or window is made on one side of the lamina to alleviate the compression of the spinal cord. The lamina is then restructured by a small plate which allows the spinal canal to increase in size without losing stability or movement in the vertebrae. This procedure can be completed at single or multiple levels.
The Xspan(TM) Laminoplasty Fixation System is intended for use in the lower cervical and upper thoracic spine (C3-T3). "We are very pleased to have received clearance for Xspan," stated Dr. David Kirschman, CSO, EVP, and Director of Xtant Medical. "This system will allow Xtant Medical to further differentiate itself from the competition and will better serve the growing needs of our surgeon partners."
Xtant Medical estimates the world wide market for laminoplasty at $110M and growing. Xspan will be available to a limited number of key surgeons in the second fiscal quarter of 2016, with a larger general release to follow later in 2016.
About Xtant Medical Holdings
Xtant Medical Holdings, Inc. (NYSE MKT:XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.
Recent XTNT News
- Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
- Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024 • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:13:22 PM
- Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:05:39 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 10:10:19 PM
- Xtant Medical to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:11:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:42:41 PM
- Xtant Medical to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/09/2023 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:15:30 PM
- Xtant Medical Announces Record Third Quarter Revenue of $25 Million • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
- Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023 • GlobeNewswire Inc. • 11/02/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 09:00:32 PM
- Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical • GlobeNewswire Inc. • 10/23/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 08:43:14 PM
- Xtant Medical Highlights Growing Product Portfolio at NASS 2023 • GlobeNewswire Inc. • 10/12/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 09:20:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 09:11:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 09:01:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:46:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:38:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:18:49 PM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM